Literature DB >> 26519622

The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.

Donna L White1, Peter Richardson2, Nabiha Tayoub3, Jessica A Davila2, Fasiha Kanwal3, Hashem B El-Serag4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26519622      PMCID： PMC5082743          DOI： 10.1053/j.gastro.2015.10.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients.

Authors:  Peter Richardson; Zhigang Duan; Jennifer Kramer; Jessica A Davila; Gia L Tyson; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-07       Impact factor: 11.382

3.  Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data.

Authors:  Peter Richardson; Louise Henderson; Jessica A Davila; Jennifer R Kramer; Conar P Fitton; G John Chen; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2010-09-16       Impact factor: 3.199

Review 4.  Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

Authors:  Samir Gupta; Stephen Bent; Jeffrey Kohlwes
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

5.  A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.

Authors:  Hashem B El-Serag; Fasiha Kanwal; Jessica A Davila; Jennifer Kramer; Peter Richardson
Journal:  Gastroenterology       Date:  2014-01-23       Impact factor: 22.682
  5 in total
  19 in total

1.  Should AFP (or any biomarkers) be used for HCC surveillance?

Authors:  Hager F Ahmed Mohammed; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2017-04-28

2.  Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C.

Authors:  George N Ioannou; Pamela K Green; Lauren A Beste; Elijah J Mun; Kathleen F Kerr; Kristin Berry
Journal:  J Hepatol       Date:  2018-08-21       Impact factor: 25.083

3.  Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.

Authors:  George N Ioannou; Pamela Green; Elliott Lowy; Elijah J Mun; Kristin Berry
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

4.  Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis.

Authors:  Nabihah Tayob; Israel Christie; Peter Richardson; Ziding Feng; Donna L White; Jessica Davila; Douglas A Corley; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2018-12-14       Impact factor: 11.382

5.  Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.

Authors:  George N Ioannou; Pamela Green; Kathleen F Kerr; Kristin Berry
Journal:  J Hepatol       Date:  2019-05-28       Impact factor: 25.083

6.  Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.

Authors:  George N Ioannou; Lauren A Beste; Pamela K Green; Amit G Singal; Elliot B Tapper; Akbar K Waljee; Richard K Sterling; Jordan J Feld; David E Kaplan; Tamar H Taddei; Kristin Berry
Journal:  Gastroenterology       Date:  2019-07-26       Impact factor: 22.682

Review 7.  Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.

Authors:  Fasiha Kanwal; Amit G Singal
Journal:  Gastroenterology       Date:  2019-04-12       Impact factor: 22.682

8.  No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.

Authors:  Elijah J Mun; Pamela Green; Kristin Berry; George N Ioannou
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-01       Impact factor: 2.566

Review 9.  Epidemiology and surveillance for hepatocellular carcinoma: New trends.

Authors:  Amit G Singal; Pietro Lampertico; Pierre Nahon
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

10.  High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.

Authors:  Nicole E Rich; Aarthi Parvathaneni; Ahana Sen; Mobolaji Odewole; Ana Arroyo; Arjmand R Mufti; Thomas A Kerr; Lafaine Grant; Shannan R Tujios; Marlyn J Mayo; William M Lee; Ju Dong Yang; Takeshi Yokoo; Purva Gopal; Yujin Hoshida; Hao Zhu; Adam C Yopp; Jorge A Marrero; Amit G Singal
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.487
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.